Total Payments
$6,634
2024 Payments
$284.59
Companies
54
Transactions
450
Medicare Patients
9,459
Medicare Billing
$442,821
Payment Breakdown by Category
Food & Beverage$6,540 (98.6%)
Education$94.15 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,540 | 441 | 98.6% |
| Education | $94.15 | 9 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,150 | 79 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $584.50 | 32 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $442.98 | 23 | $0 (2021) |
| Amgen Inc. | $435.31 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $336.49 | 26 | $0 (2023) |
| PFIZER INC. | $314.35 | 31 | $0 (2024) |
| Lilly USA, LLC | $298.56 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $290.28 | 17 | $0 (2020) |
| AbbVie Inc. | $229.08 | 13 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $225.52 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $284.59 | 17 | Novo Nordisk Inc ($91.02) |
| 2023 | $404.93 | 26 | Novo Nordisk Inc ($191.95) |
| 2022 | $616.89 | 27 | Novo Nordisk Inc ($251.65) |
| 2021 | $396.57 | 25 | Novo Nordisk Inc ($83.59) |
| 2020 | $276.96 | 20 | Lilly USA, LLC ($47.19) |
| 2019 | $1,181 | 77 | AstraZeneca Pharmaceuticals LP ($243.08) |
| 2018 | $1,112 | 86 | Novo Nordisk Inc ($185.58) |
| 2017 | $2,361 | 172 | Merck Sharp & Dohme Corporation ($336.34) |
All Payment Transactions
450 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Obesity | ||||||
| 08/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Obesity | ||||||
| 07/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Diabetes Care | ||||||
| 07/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Inflammation | ||||||
| 07/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Inflammation | ||||||
| 06/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diabetes Care | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Inflammation | ||||||
| 05/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Obesity | ||||||
| 04/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Diabetes | ||||||
| 04/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Obesity | ||||||
| 03/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Inflammation | ||||||
| 03/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: VACCINES | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Diabetes | ||||||
| 01/05/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: GALLSTONES | ||||||
| 12/19/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Inflammation | ||||||
| 12/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Inflammation | ||||||
| 11/30/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $48.54 | General |
| Category: Obesity | ||||||
| 11/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Inflammation | ||||||
| 11/02/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Inflammation | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: VACCINES | ||||||
| 10/25/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Inflammation | ||||||
| 10/13/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 2,053 | 4,391 | $302,516 | $109,793 |
| 2022 | 38 | 2,219 | 3,670 | $285,398 | $94,843 |
| 2021 | 41 | 2,512 | 4,318 | $314,222 | $111,377 |
| 2020 | 37 | 2,675 | 5,871 | $365,475 | $126,807 |
Total Patients
9,459
Total Services
18,250
Medicare Billing
$442,821
Procedure Codes
154
All Medicare Procedures & Services
154 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 132 | 288 | $82,080 | $33,324 | 40.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 1,020 | $33,660 | $18,918 | 56.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 93 | 405 | $32,952 | $9,510 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 58 | 58 | $16,530 | $7,084 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 54 | $11,340 | $4,739 | 41.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 101 | 131 | $9,825 | $3,760 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 54 | $8,100 | $3,623 | 44.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 125 | 236 | $14,160 | $2,420 | 17.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 108 | 138 | $8,280 | $2,271 | 27.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 30 | $2,400 | $2,151 | 89.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 120 | 250 | $6,250 | $2,100 | 33.6% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 36 | 52 | $3,640 | $2,073 | 57.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 110 | 154 | $6,930 | $2,020 | 29.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 104 | 135 | $6,075 | $1,986 | 32.7% |
| 82746 | Folic acid level, serum | Office | 2023 | 103 | 135 | $6,750 | $1,936 | 28.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 117 | 190 | $6,650 | $1,809 | 27.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 118 | 223 | $8,920 | $1,677 | 18.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 57 | 90 | $4,230 | $1,194 | 28.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 36 | $1,980 | $1,050 | 53.0% |
| 83550 | Iron binding capacity | Office | 2023 | 55 | 87 | $2,610 | $740.15 | 28.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 17 | $3,060 | $654.41 | 21.4% |
| 83540 | Iron level | Office | 2023 | 55 | 87 | $2,436 | $547.55 | 22.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 58 | $3,248 | $531.02 | 16.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 15 | 15 | $4,185 | $512.32 | 12.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $880.00 | $466.72 | 53.0% |
About Dr. Kira Alatar, MD
Dr. Kira Alatar, MD is a Family Medicine healthcare provider based in Leland, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1740274844.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kira Alatar, MD has received a total of $6,634 in payments from pharmaceutical and medical device companies, with $284.59 received in 2024. These payments were reported across 450 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($6,540).
As a Medicare-enrolled provider, Alatar has provided services to 9,459 Medicare beneficiaries, totaling 18,250 services with total Medicare billing of $442,821. Data is available for 4 years (2020–2023), covering 154 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Leland, NC
- Active Since 09/02/2005
- Last Updated 01/30/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740274844
Products in Payments
- FARXIGA (Drug) $503.14
- Ozempic (Drug) $297.64
- JANUVIA (Drug) $269.53
- Saxenda (Drug) $250.74
- JARDIANCE (Drug) $247.64
- XIFAXAN (Drug) $221.62
- Otezla (Drug) $203.77
- Wegovy (Drug) $170.71
- Vascepa (Drug) $157.65
- Belviq (Drug) $136.83
- INVOKANA (Drug) $123.46
- CHANTIX (Drug) $119.47
- SOLIQUA (Drug) $115.96
- BELSOMRA (Drug) $112.16
- Trintellix (Drug) $111.10
- Prolia (Biological) $100.97
- Aimovig (Biological) $98.19
- Victoza (Drug) $96.35
- VRAYLAR (Drug) $95.76
- ANORO (Drug) $95.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Leland
Robert Johnson, Md, MD
Family Medicine — Payments: $5,711
Family Medicine $5,711
Dr. Anette Bodoky, M.d, M.D
Family Medicine — Payments: $3,461
Family Medicine $3,461
Dr. Lekeshia Jarrett, Md, MD
Family Medicine — Payments: $2,607
Family Medicine $2,607
Gloria Vreeland, M.d, M.D
Family Medicine — Payments: $1,629
Family Medicine $1,629
Rajya Atluri, M.d, M.D
Family Medicine — Payments: $1,041
Family Medicine $1,041
Joana Carnahan, D.o, D.O
Family Medicine — Payments: $994.40
Family Medicine $994.40